Representatives from 27 Asian countries gathered in Tokyo last month to increase their understanding of Therapeutic Use Exemptions (TUEs) in anti-doping programs.
The two-day seminar was hosted by the Japan Anti-Doping Agency (JADA) in partnership with WADA, and was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government.
“Our objective was to discuss in detail the TUE process and to help physicians and managers within the Regional Anti-Doping Organizations (RADOs) and National Anti-Doping Organizations (NADOs) to manage this process effectively,” explained WADA Medical Director Dr. Alan Vernec (pictured).
“The TUE process is a fundamental part of anti-doping and a critical element that allows athletes with legitimate medical conditions to participate in sport.”
In addition to presentations, breakout sessions were used to discuss challenging TUE cases. Joining Dr. Vernec in leading the breakout sessions was Dr. Takao Akama, JADA Vice-President and Chair of JADA’s TUE Committee.
“I was pleased at the opportunity to engage with seminar participants and delighted at the lively discussions that ensued,” added Dr. Vernec.
Participating with Dr. Vernec as guest speakers were Mr. Joseph de Pencier, CEO of the Institute of National Anti-Doping Organizations (iNADO) and Ms. Natanya Potoi-Ulia, Executive Officer of the Oceania RADO.
Upcoming revisions to the International Standard on TUEs were also discussed, while Dr. Vernec used the occasion to present an introductory session on the Athlete Biological Passport (ABP).
Eighty officials from across Asia participated in the seminar on day one, while 150 attended the second day when it was opened to all JADA stakeholders.